• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者肠道微生物途径和毒力因子的改变。

Alterations of gut microbial pathways and virulence factors in hemodialysis patients.

机构信息

Department of Environmental Ecological Engineering, School of Environmental Science and Engineering, Nanjing University of Information Science and Technology, Nanjing, China.

School of Marine Sciences, Nanjing University of Information Science and Technology, Nanjing, China.

出版信息

Front Cell Infect Microbiol. 2022 Aug 26;12:904284. doi: 10.3389/fcimb.2022.904284. eCollection 2022.

DOI:10.3389/fcimb.2022.904284
PMID:36093194
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9461950/
Abstract

Alterations in gut microbiota might contribute to uremic toxicity and immune dysregulation in patients with end-stage renal disease. Hemodialysis patients are prone to infection and higher mortality following sepsis. The virulence factors in the gut metagenome have not been well studied in hemodialysis patients, which could be employed by microorganisms to successfully thrive and flourish in their hosts. In this study, we performed shotgun metagenomics sequencing on fecal DNA collected from 16 control subjects and 24 hemodialysis patients. Our analysis shows that a number of microbial species, metabolic pathways, antibiotic resistance, and virulence factors were significantly altered in hemodialysis patients compared with controls. In particular, erythromycin resistance methylase, pyridoxamine 5-phosphate oxidase, and streptothricin-acetyl-transferase were significantly increased in hemodialysis patients. The findings in our study laid a valuable foundation to further elucidate the causative role of virulence factors in predisposing HD patients to infection and to develop treatment strategies to reduce the genetic capacities of antibiotic resistance and virulence factors in HD patients.

摘要

肠道微生物群的改变可能导致终末期肾病患者的尿毒症毒性和免疫失调。血液透析患者在发生脓毒症后容易感染和死亡率更高。在血液透析患者中,尚未很好地研究肠道宏基因组中的毒力因子,这些因子可能被微生物用来在宿主中成功地生存和繁殖。在这项研究中,我们对 16 名对照者和 24 名血液透析患者的粪便 DNA 进行了鸟枪法宏基因组测序。我们的分析表明,与对照组相比,血液透析患者的许多微生物物种、代谢途径、抗生素耐药性和毒力因子发生了显著改变。特别是,血液透析患者中红霉素耐药甲基酶、吡哆醇 5-磷酸氧化酶和链霉菌乙酰转移酶显著增加。我们的研究结果为进一步阐明毒力因子在易感染血液透析患者中的致病作用奠定了有价值的基础,并为开发治疗策略以降低血液透析患者抗生素耐药性和毒力因子的遗传能力提供了依据。

相似文献

1
Alterations of gut microbial pathways and virulence factors in hemodialysis patients.血液透析患者肠道微生物途径和毒力因子的改变。
Front Cell Infect Microbiol. 2022 Aug 26;12:904284. doi: 10.3389/fcimb.2022.904284. eCollection 2022.
2
Identification of Gut Microbiome Signatures Associated with Indole Pathway in Tryptophan Metabolism in Patients Undergoing Hemodialysis.鉴定与血液透析患者色氨酸代谢中吲哚途径相关的肠道微生物组特征。
Biomolecules. 2024 May 24;14(6):623. doi: 10.3390/biom14060623.
3
The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses.血液透析和腹膜透析对终末期肾病患者肠道微生物群的影响以及肠道微生物群与患者预后的关系。
Front Cell Infect Microbiol. 2021 Mar 23;11:579386. doi: 10.3389/fcimb.2021.579386. eCollection 2021.
4
Quantitative Assessment of Shotgun Metagenomics and 16S rDNA Amplicon Sequencing in the Study of Human Gut Microbiome. shotgun 宏基因组学和 16S rDNA 扩增子测序在人类肠道微生物组研究中的定量评估
OMICS. 2018 Apr;22(4):248-254. doi: 10.1089/omi.2018.0013.
5
Gut microbiome of endangered Tor putitora (Ham.) as a reservoir of antibiotic resistance genes and pathogens associated with fish health.濒危物种圆口铜鱼肠道微生物组是抗生素耐药基因和与鱼类健康相关病原体的储存库。
BMC Microbiol. 2020 Aug 12;20(1):249. doi: 10.1186/s12866-020-01911-7.
6
Human reference gut microbiome catalog including newly assembled genomes from under-represented Asian metagenomes.人类参考肠道微生物组目录,包括来自代表性不足的亚洲宏基因组的新组装基因组。
Genome Med. 2021 Aug 27;13(1):134. doi: 10.1186/s13073-021-00950-7.
7
Relationship between Gut Microbiota and Phosphorus Metabolism in Hemodialysis Patients: A Preliminary Exploration.血液透析患者肠道微生物群与磷代谢的关系:初步探索。
Chin Med J (Engl). 2018 Dec 5;131(23):2792-2799. doi: 10.4103/0366-6999.246059.
8
Connections between the human gut microbiome and gestational diabetes mellitus.人类肠道微生物群与妊娠期糖尿病之间的联系。
Gigascience. 2017 Aug 1;6(8):1-12. doi: 10.1093/gigascience/gix058.
9
The Gut-Muscle Axis in Older Subjects with Low Muscle Mass and Performance: A Proof of Concept Study Exploring Fecal Microbiota Composition and Function with Shotgun Metagenomics Sequencing.低肌肉量和身体机能老年人的“肠-肌肉轴”:一项利用宏基因组测序技术探索粪便微生物群落组成和功能的概念验证研究。
Int J Mol Sci. 2020 Nov 25;21(23):8946. doi: 10.3390/ijms21238946.
10
Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese.基于宏基因组关联研究揭示了日本系统性红斑狼疮患者肠道微生物组的疾病特异性特征。
Ann Rheum Dis. 2021 Dec;80(12):1575-1583. doi: 10.1136/annrheumdis-2021-220687. Epub 2021 Aug 23.

引用本文的文献

1
Microbiota and kidney disease: the road ahead.微生物群与肾脏疾病:未来之路
Nat Rev Nephrol. 2025 Oct;21(10):702-716. doi: 10.1038/s41581-025-00988-5. Epub 2025 Jul 28.
2
Plasma TMAO Concentrations and Gut Microbiota Composition in Subjects with and Without Metabolic Syndrome: Results from Pilot Study.患有和未患有代谢综合征的受试者的血浆氧化三甲胺浓度与肠道微生物群组成:初步研究结果
Metabolites. 2025 May 30;15(6):364. doi: 10.3390/metabo15060364.
3
Immune-microbiota dysregulation in maintenance hemodialysis: a 16S rRNA sequencing-based analysis of gut flora and T cell profiles.

本文引用的文献

1
The Impact of CKD on Uremic Toxins and Gut Microbiota.慢性肾脏病对尿毒症毒素和肠道微生物群的影响。
Toxins (Basel). 2021 Mar 31;13(4):252. doi: 10.3390/toxins13040252.
2
Gut Microbiota and Host Cometabolism Are Altered by Patiromer-Induced Changes in Serum and Stool Potassium.帕替罗姆诱导的血清和粪便钾变化改变了肠道微生物群和宿主共代谢。
Kidney Int Rep. 2020 Dec 29;6(3):821-829. doi: 10.1016/j.ekir.2020.12.026. eCollection 2021 Mar.
3
Gut dysbiosis and mortality in hemodialysis patients.肠道菌群失调与血液透析患者的死亡率。
维持性血液透析中的免疫-微生物群失调:基于16S rRNA测序的肠道菌群和T细胞谱分析
Ren Fail. 2025 Dec;47(1):2498630. doi: 10.1080/0886022X.2025.2498630. Epub 2025 May 15.
4
Gut microbiome dynamics of patients on dialysis: implications for complications and treatment.透析患者的肠道微生物群动态:对并发症和治疗的影响。
Front Pharmacol. 2025 Apr 25;16:1470232. doi: 10.3389/fphar.2025.1470232. eCollection 2025.
5
The Role of the Gut Microbiota in Complications among Hemodialysis Patients.肠道微生物群在血液透析患者并发症中的作用
Microorganisms. 2024 Sep 12;12(9):1878. doi: 10.3390/microorganisms12091878.
6
Pyridoxal 5'-Phosphate Biosynthesis by Pyridox-(am)-ine 5'-Phosphate Oxidase: Species-Specific Features.吡哆醛 5'-磷酸通过吡哆胺 5'-磷酸氧化酶的生物合成:种属特异性特征。
Int J Mol Sci. 2024 Mar 9;25(6):3174. doi: 10.3390/ijms25063174.
7
Comparison of risk prediction models for the progression of pelvic inflammatory disease patients to sepsis: Cox regression model and machine learning model.盆腔炎患者进展为脓毒症的风险预测模型比较:Cox回归模型与机器学习模型
Heliyon. 2023 Dec 2;10(1):e23148. doi: 10.1016/j.heliyon.2023.e23148. eCollection 2024 Jan 15.
8
Chronic Strongyloides stercoralis infection increases presence of the Ruminococcus torques group in the gut and alters the microbial proteome.慢性粪类圆线虫感染增加了肠道中 Ruminococcus torques 菌属的存在,并改变了微生物蛋白质组。
Sci Rep. 2023 Mar 14;13(1):4216. doi: 10.1038/s41598-023-31118-5.
NPJ Biofilms Microbiomes. 2021 Mar 3;7(1):20. doi: 10.1038/s41522-021-00191-x.
4
Metagenomic profiling of gut microbiome in early chronic kidney disease.早期慢性肾脏病患者肠道微生物组的宏基因组分析。
Nephrol Dial Transplant. 2021 Aug 27;36(9):1675-1684. doi: 10.1093/ndt/gfaa122.
5
Microbial Virulence Factors.微生物毒力因子。
Int J Mol Sci. 2020 Jul 27;21(15):5320. doi: 10.3390/ijms21155320.
6
Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents.肠道菌群紊乱改变宿主代谢组学,并影响人类和啮齿动物的肾衰竭。
Gut. 2020 Dec;69(12):2131-2142. doi: 10.1136/gutjnl-2019-319766. Epub 2020 Apr 2.
7
Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.肠道微生物群与慢性肾脏病:介导胃肠-肾轴新通讯的证据和机制。
Pflugers Arch. 2020 Mar;472(3):303-320. doi: 10.1007/s00424-020-02352-x. Epub 2020 Feb 17.
8
Short-term and long-term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota.含铋剂四联疗法根除幽门螺杆菌对肠道微生物群的短期和长期影响。
J Gastroenterol Hepatol. 2019 Nov;34(11):1968-1976. doi: 10.1111/jgh.14736. Epub 2019 Jul 16.
9
Chronic kidney disease and the gut microbiome.慢性肾脏病与肠道微生物群
Am J Physiol Renal Physiol. 2019 Jun 1;316(6):F1211-F1217. doi: 10.1152/ajprenal.00298.2018. Epub 2019 Mar 13.
10
US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2018年年报:美国肾脏疾病流行病学
Am J Kidney Dis. 2019 Mar;73(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2019.01.001. Epub 2019 Feb 21.